 |
Articles: General Pharma |
Prior Articles
Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME Drug Eluting Stent, Advancing Leadership Position
Abbott, 06/24/09
Too much market focus can be a bad thing
PharmExec, 06/24/09 New Avatec Plus 3-Nitro Combination-Use Approval Now Brings Turkey Growers the Only Ionophore-Based Coccidiosis Control with the Performance of 3-Nitro
King Pharmaceuticals, 06/24/09
Free full text
AVI BioPharma Under Contract with U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu
AVI BioPharma, 06/23/09
Free full text
AstraZeneca issues new report on US responsible business efforts
AstraZeneca, 06/23/09
Free full text
More effective connection between labs, scientists, and instruments accelerates product development and release
PharmExec, 06/23/09 Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
Merck & Co., 06/23/09
Free full text
Merck and Co., Inc. and Drugs for Neglected Diseases initiative Collaborate to Find Treatments for World's Most Neglected Tropical Diseases
Merck & Co., 06/23/09
Free full text
The Earth Institute and Merck and Co., Inc./The Merck Company Foundation partner to strengthen health services in rural Africa
Merck & Co., 06/23/09
Free full text
Merck Prices $4.25 Billion Debt Offering
Merck & Co., 06/23/09
Free full text
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
BioVail Corporation, 06/23/09
Free full text
Expedition to Mount Everest offers new insights into chronic disease
Boehringer Ingelheim, 06/23/09
Free full text
MORE-CARE Trial to Assess Remote Monitoring Impact on Heart Failure Patients and Healthcare Utilization
Medtronic, 06/23/09
Free full text
Responses After Completion of Therapy Increase Pixantrone CR/CRu Rate to 24% and ORR to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial
Cell Therapeutics, 06/23/09
Free full text
ImmunoGen, Inc. Announces Exercise of Over-allotment Option
ImmunoGen, Inc., 06/23/09
Free full text
Plan to attend the Leadership Summit
American Hospital Association News, 06/23/09
Free full text
PhRMA Statement on AARP-White House Press Conference
PhRMA, 06/23/09
Free full text
Enzon Commences Phase II Trial of PEG-SN38
Enzon Pharmaceuticals, 06/23/09
Free full text
Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
Amgen, 06/23/09
Free full text
WebMD, HLTH Again Try to Merge
HealthDataManagement, 06/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
